back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-08-21 20:07 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,666,675 vol |
416,669 | |
| Filed 2024-08-21 20:06 Tx date 2024-08-16 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-400,000 vol |
100,000 | |
| Filed 2024-07-22 19:28 Tx date 2024-07-19 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,000
+350,000 vol $0.22 each |
500,000 | |
| Filed 2023-08-25 12:17 Tx date 2023-08-21 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$72,000
+400,000 vol $0.18 each |
2,083,344 | |
| Filed 2023-01-10 11:44 Tx date 2023-01-09 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,000
+150,000 vol $0.26 each |
150,000 | |
| Filed 2023-01-10 11:43 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-11-08 10:17 Tx date 2022-11-03 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$72,000
+400,000 vol $0.18 each |
1,683,344 | |
| Filed 2022-04-27 12:57 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,283,344 | ||
| Filed 2022-04-25 12:29 Tx date 2022-04-18 |
$HBP
Helix BioPharma Corp. |
Leszczynski, Jerzy Alfred
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
627,500 |